International Orthopaedics

, Volume 38, Issue 8, pp 1591–1595

Targeted pre-operative autologous blood donation: a prospective study of two thousand and three hundred and fifty total hip arthroplasties

  • Jad Bou Monsef
  • Mark P. Figgie
  • David Mayman
  • Friedrich Boettner
Original Paper



Pre-operative donation of autologous blood has been widely used in elective joint replacement procedures to avoid the risks of allogeneic blood transfusions. However, the high percentage of wasted autologous blood questions the general efficacy of pre-operative autologous blood donation (PABD) for all patients undergoing hip replacement. This study prospectively investigates the impact of a targeted pre-operative autologous blood donation protocol for anaemic patients on allogeneic and overall transfusion rates in 2,350 unilateral primary total hip arthroplasty procedures.


Patients with pre-operative haemoglobin less than 12.5 g/dL were advised to donate one unit of autologous blood seven to 15 days prior to the date of surgery. The targeted protocol was followed by 2,251 patients: 280 out of 367 anaemic patients donated while 1,971 out of 1,983 non-anaemic patients did not donate.


Results showed a significantly lower rate of allogeneic transfusion for anaemic patients who predonated than anaemic patients who did not (13 % vs. 37 % respectively, p < 0.001). Overall transfusion rates for patients who followed the protocol (n = 2,251) were found to be 0.17 units/patient compared to previously reported numbers of 0.75 units/patient when routine donation was used. Among the 2,251 patients who followed the protocol, only 140 patients (6 %) had their autologous blood wasted, in contrast to values reported in the literature ranging from 14 % up to 50 %.


Targeted PABD reduces the need for allogeneic blood transfusion in anaemic patients and significantly reduces the overall number of transfusions compared to routine pre-operative autologous donation.


Anaemia Total hip arthroplasty Blood management Preoperative autologous blood donation Allogeneic Transfusion 


  1. 1.
    Friedman R, Homering M, Holberg G, Berkowitz SD (2014) Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am 96(4):272–278. doi:10.2106/JBJS.L.01268 PubMedCrossRefGoogle Scholar
  2. 2.
    Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, Attarian DE, Grant SA, Green CL, Vail TP, Bolognesi MP (2014) Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am 96(4):279–284. doi:10.2106/JBJS.L.01041 PubMedCrossRefGoogle Scholar
  3. 3.
    Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL (2000) Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am 82(1):89–100PubMedGoogle Scholar
  4. 4.
    Parvizi J, Chaudhry S, Rasouli MR, Pulido L, Joshi A, Herman JH, Rothman RH (2011) Who needs autologous blood donation in joint replacement? J Knee Surg 24(1):25–31PubMedCrossRefGoogle Scholar
  5. 5.
    Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81(1):2–10PubMedGoogle Scholar
  6. 6.
    Salido JA, Marin LA, Gomez LA, Zorrilla P, Martinez C (2002) Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 84-A(2):216–220PubMedGoogle Scholar
  7. 7.
    de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC (1996) Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop (Belle Mead NJ) 25(8):533–542Google Scholar
  8. 8.
    Keating EM, Meding JB, Faris PM, Ritter MA (1998) Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 357:50–59PubMedCrossRefGoogle Scholar
  9. 9.
    Aggarwal AK, Shashikanth VS, Marwaha N (2014) Platelet-rich plasma prevents blood loss and pain and enhances early functional outcome after total knee arthroplasty: a prospective randomised controlled study. Int Orthop 38(2):387–395. doi:10.1007/s00264-013-2136-6 PubMedCrossRefGoogle Scholar
  10. 10.
    Buljan M, Nemet D, Golubic-Cepulic B, Bicanic G, Tripkovic B, Delimar D (2012) Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty. Int Orthop 36(4):703–709. doi:10.1007/s00264-011-1367-7 PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Munoz M, Garcia-Erce JA, Villar I, Thomas D (2009) Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations. Vox Sang 96(1):1–13. doi:10.1111/j.1423-0410.2008.01108.x PubMedCrossRefGoogle Scholar
  12. 12.
    Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL (2003) Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 43(4):459–469PubMedCrossRefGoogle Scholar
  13. 13.
    Sharrock NE, Salvati EA (1996) Hypotensive epidural anesthesia for total hip arthroplasty: a review. Acta Orthop Scand 67(1):91–107PubMedCrossRefGoogle Scholar
  14. 14.
    Sukeik M, Alshryda S, Haddad FS, Mason JM (2011) Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg 93(1):39–46. doi:10.1302/0301-620X.93B1.24984 CrossRefGoogle Scholar
  15. 15.
    Millett PJ, Porramatikul M, Chen N, Zurakowski D, Warner JJ (2006) Analysis of transfusion predictors in shoulder arthroplasty. J Bone Joint Surg Am 88(6):1223–1230. doi:10.2106/JBJS.E.00706 PubMedCrossRefGoogle Scholar
  16. 16.
    Boettner F, Altneu EI, Williams BA, Hepinstall M, Sculco TP (2009) Nonanemic patients do not benefit from autologous blood donation before total hip replacement. HSS J 6(1):66–70. doi:10.1007/s11420-009-9145-4 Google Scholar
  17. 17.
    Sculco TP (1998) Global blood management in orthopaedic surgery. Clin Orthop Relat Res 357:43–49PubMedCrossRefGoogle Scholar
  18. 18.
    Henry DA, Carless PA, Moxey AJ, O’Connell D, Forgie MA, Wells PS, Fergusson D (2002) Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2):CD003602. doi:10.1002/14651858.CD003602
  19. 19.
    Callaghan JJ, Spitzer AI (2000) Blood management and patient specific transfusion options in total joint replacement surgery. Iowa Orthop J 20:36–45PubMedCentralPubMedGoogle Scholar
  20. 20.
    Billote DB, Glisson SN, Green D, Wixson RL (2002) A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 84-A(8):1299–1304PubMedGoogle Scholar
  21. 21.
    Jakovina Blazekovic S, Bicanic G, Hrabac P, Tripkovic B, Delimar D (2014) Pre-operative autologous blood donation versus no blood donation in total knee arthroplasty: a prospective randomised trial. Int Orthop 38(2):341–346. doi:10.1007/s00264-013-2185-x PubMedCrossRefGoogle Scholar
  22. 22.
    Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, Fink A, Brook R (1995) The cost effectiveness of preoperative autologous blood donations. N Engl J Med 332(11):719–724. doi:10.1056/NEJM199503163321106 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Jad Bou Monsef
    • 1
  • Mark P. Figgie
    • 1
  • David Mayman
    • 1
  • Friedrich Boettner
    • 1
  1. 1.Hospital for Special SurgeryNew YorkUSA

Personalised recommendations